title: Quantitative investigation of physical factors contributing to gold nanoparticle-mediated proton dose enhancement.
abstract: Some investigators have shown tumor cell killing enhancement in vitro and tumor regression in mice associated with the loading of gold nanoparticles (GNPs) before proton treatments. Several Monte Carlo (MC) investigations have also demonstrated GNP-mediated proton dose enhancement. However, further studies need to be done to quantify the individual physical factors that contribute to the dose enhancement or cell-kill enhancement (or radiosensitization). Thus, the current study investigated the contributions of particle-induced x-ray emission (PIXE), particle-induced gamma-ray emission (PIGE), Auger and secondary electrons, and activation products towards the total dose enhancement. Specifically, GNP-mediated dose enhancement was measured using strips of radiochromic film that were inserted into vials of cylindrical GNPs, i.e. gold nanorods (GNRs), dispersed in a saline solution (0.3 mg of GNRs/g or 0.03% of GNRs by weight), as well as vials containing water only, before proton irradiation. MC simulations were also performed with the tool for particle simulation code using the film measurement setup. Additionally, a high-purity germanium detector system was used to measure the photon spectrum originating from activation products created from the interaction of protons and spherical GNPs present in a saline solution (20 mg of GNPs/g or 2% of GNPs by weight). The dose enhancement due to PIXE/PIGE recorded on the films in the GNR-loaded saline solution was less than the experimental uncertainty of the film dosimetry (<2%). MC simulations showed highly localized dose enhancement (up to a factor 17) in the immediate vicinity (<100 nm) of GNRs, compared with hypothetical water nanorods (WNRs), mostly due to GNR-originated Auger/secondary electrons; however, the average dose enhancement over the entire GNR-loaded vial was found to be minimal (0.1%). The dose enhancement due to the activation products from GNPs was minimal (<0.1%) as well. In conclusion, under the currently investigated conditions that are considered clinically relevant, PIXE, PIGE, and activation products contribute minimally to GNP/GNR-mediated proton dose enhancement, whereas Auger/secondary electrons contribute significantly but only at short distances (<100 nm) from GNPs/GNRs.
authors.affiliation: Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Jongmin
authors.initials: J
authors.lastname: Cho
authors.forename: Carlos
authors.initials: C
authors.lastname: Gonzalez-Lepera
authors.forename: Nivedh
authors.initials: N
authors.lastname: Manohar
authors.forename: Matthew
authors.initials: M
authors.lastname: Kerr
authors.forename: Sunil
authors.initials: S
authors.lastname: Krishnan
authors.forename: Sang Hyun
authors.initials: SH
authors.lastname: Cho
mesh_terms: D000465:Algorithms; D000818:Animals; D005720:Gamma Rays; D006046:Gold / Q000528:radiation effects; D053768:Metal Nanoparticles / Q000737:chemistry / Q000528:radiation effects* / Q000627:therapeutic use; D051379:Mice; D061766:Proton Therapy / Q000379:methods*; D011522:Protons; D011829:Radiation Dosage; D014965:X-Rays
chemical_list: D011522:Protons; D006046:Gold